Does POSACONAZOLE Cause Interstitial lung disease? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Interstitial lung disease have been filed in association with POSACONAZOLE (POSACONAZOLE). This represents 0.3% of all adverse event reports for POSACONAZOLE.
18
Reports of Interstitial lung disease with POSACONAZOLE
0.3%
of all POSACONAZOLE reports
2
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From POSACONAZOLE?
Of the 18 reports, 2 (11.1%) resulted in death, 10 (55.6%) required hospitalization, and 5 (27.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POSACONAZOLE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does POSACONAZOLE Cause?
Drug ineffective (785)
Product use in unapproved indication (661)
Off label use (430)
Drug interaction (383)
Death (369)
Condition aggravated (214)
Pyrexia (185)
Neutropenia (181)
Product use issue (181)
Febrile neutropenia (178)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which POSACONAZOLE Alternatives Have Lower Interstitial lung disease Risk?
POSACONAZOLE vs POTASSIUM
POSACONAZOLE vs POTASSIUM, DIBASIC
POSACONAZOLE vs POTASSIUM IODIDE
POSACONAZOLE vs POTASSIUM, MONOBASIC
POSACONAZOLE vs POTASSIUM\SODIUM FLUORIDE